SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as the community rallies around the tokenization of the pseudonymous Bitcoin creator, Satoshi Nakamoto, emphasizing the narrative's significance and potential. The community buzzes about an upcoming feature on the Mario Nawfal space, anticipating increased attention and a potential price surge. Many believe $SATOSHI represents the spirit of crypto and is destined to become a blue-chip meme coin.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as the community rallies around the token's resilience and potential within the Solana ecosystem. Discussions highlight WAGMI's strong holder base and its ability to maintain stability during market fluctuations, with many anticipating significant gains as Solana's liquidity expands. Some users are suggesting that it should be added to watchlists.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is trending as community members discuss the company's strong free cash flow and potential AI infrastructure play, especially highlighting its partnership with Palantir. Bulls are optimistic about Lumen's future, citing insider buying and potential for significant growth. Some traders caution about debt levels and potential consolidation after the recent surge.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors discuss its potential for a breakout following recent consolidation, with community members highlighting upcoming catalysts and overall bullish sentiment despite some concerns about short positions and past performance. Discussions also center on the company's growth prospects, revenue guidance, and potential impact of the CMS policy. Some traders are expressing frustration with the stock's sideways movement and look for a breakout soon.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple's stock is trending as the community digests mixed reactions to the latest earnings report and forward guidance, with some citing concerns over iPhone sales and AI strategy. Despite robust revenue, traders are debating the stock's valuation and potential pullback, while also monitoring hints of AI acquisitions and analyst target adjustments. Overall sentiment appears cautiously optimistic, as some traders see potential for gains while others remain skeptical.

Boqii Holding Ltd. operates as a holding company with interest in operating online pet stores. It provides services through its subsidiaries. The company was founded by Liang Hao, Tang Yingzhi, and Chen Di in December 2007 and is headquartered in Shanghai, China.

Boqii Holding Limited - Ordinary Shares - Class A

Boqii Holding Limited - ADR

Boqii Holding is experiencing significant volatility, leading to active discussions about potential manipulation and whether it's a "pump and dump" scheme. The stock's dramatic price swings are prompting traders to debate entry and exit strategies, with some anticipating further upward momentum while others warn of a potential crash. Community members are also noting the stock's history of sharp halts and comparing it to other volatile Chinese stocks.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

$SLAP is trending, with community members highlighting the project's strong team, real-world partnerships including sponsored athletes, and staking rewards. The community emphasizes that $SLAP is more than just a meme, but rather a lifestyle brand. Chatter also mentions an upcoming fight for their MMA fighter Karolina Arm.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies is trending amid discussions around a potential short squeeze and upcoming earnings, with community members debating whether recent price action indicates manipulation or a buying opportunity. Bullish sentiment is fueled by anticipation of future benefits from acquisitions and potential interest rate cuts, while bears cite concerns over expenses and market volatility. The stock's long-term potential as a dominant player in the homeownership market is also a key talking point.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

DXCM is trending amidst a short report alleging safety issues with the G7 device, triggering a sell-off despite some analysts defending the stock and Goldman Sachs identifying potential upside. Community discussion revolves around the validity of the report, potential legal action, product quality concerns, and the company's response, with some seeing a buying opportunity while others anticipate further declines. The debate includes comparisons to competitors and concerns about management and future growth.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the Platform and Devices segments. The Platform segment includes digital advertising and related services including the demand-side platform and content distribution services such as subscription and transaction revenue shares, media and entertainment promotional spending, the sale of premium subscriptions, and the sale of branded channel buttons on remote controls. The Devices segment is involved in the sale of streaming players, audio products, smart home products, and accessories that are sold through retailers and distributors, as well as directly to customers through the company’s website. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

ROKU is trending amid discussions around its recent performance and future potential, with community members debating its valuation and potential breakout above $100. Bullish sentiment is fueled by positive platform revenue growth and strategic partnerships, while bears express concerns about competition and historical resistance at key price levels. The stock's behavior around the $100 mark remains a central talking point, influencing short-term trading strategies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Futures Rebound Lifted By Strong Amazon, Apple Earnings

Futures Rebound Lifted By Strong Amazon, Apple Earnings US equity futures rebound from the Thursday drop, led by Mag 7. As of 8:00am ET, S&P futures are 0.8% higher and Nasdaq futures gain 1.2%, on...

Stock Market Today: Traders Seek Turnaround Trade to Cap off Hallow-Week

This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here.Happy Friday. This is TheStreet's Stock...

<ul class="summary-bullets"><li>Investors focused on Dexcom’s lower gross margin of 61.3%, down about 170 basis points year-over-year, despite record revenue and earnings.</li><li>The company said elevated scrap and freight costs would continue to pressure margins in the near term, even as efficiency improvements are underway.</li><li>Some retail traders viewed the decline as a buying opportunity, calling the after-hours drop “uncalled for.”&nbsp;</li></ul>Dexcom shares slid 13% in after-hours trading on Thursday, as investors looked past a record third-quarter (Q3) profit and focused instead on rising costs and a cautious outlook for next year.The glucose monitoring company reported $1.21 billion in revenue for Q3, up 22% year over year, driven by strong demand across the U.S. and international markets. Net income jumped to $242.5 million, or $0.61 per share, its highest ever.Dexcom also raised its full-year revenue forecast to $4.63-$4.65 billion, representing around 15% growth. However, the company’s upbeat sales&nbsp;weren’t enough to offset concerns about profitability, as it said gross margins will remain near 61%, down about 170 basis points year over year.<h2 class="st-heading-2">Margin Pressure And Outlook</h2>The company acknowledged that elevated scrap rates and freight costs continued to eat into profits. Management said the hit was “roughly half and half” between manufacturing waste and shipping expenses, though both are expected to ease gradually in the coming quarters.Looking ahead, Dexcom projected double-digit revenue growth in 2026, but slightly below Wall Street’s expectations. The forecast does not yet include potential benefits from broader insurance coverage for type 2 diabetes patients, which the company said could provide upside later on.Dexcom added that its new 15-day G7 sensor, currently rolling out to users, will have a limited impact this year but should meaningfully boost margins and growth in 2026 once it gains wider reimbursement.<h2 class="st-heading-2">Growth Drivers Remain Intact</h2>Despite the market reaction, Dexcom’s underlying growth story remains strong. The company continues to expand its reach in the type 2 diabetes market, now covering nearly 6 million non-insulin patients in the U.S.International revenue grew 22%, led by strong momentum in France and Canada following new reimbursement coverage. Its consumer-focused continuous glucose monitor, Stelo, topped $100 million in sales within its first year, with plans to launch in more markets in 2026. Dexcom ended the quarter with over $3.3 billion in cash.<h2 class="st-heading-2">Stocktwits Traders Stay Bullish Despite Selloff</h2>On Stocktwits, retail sentiment for Dexcom was ‘extremely bullish’ amid a 921% surge in 24-hour message volume.<figure class="image"><img style="aspect-ratio:959/126;" src="https://news.stocktwits-cdn.com/dxcm_ss_jpg_7ecd09626d.webp" alt="dxcm ss.jpg" width="959" height="126"><figcaption>DXCM sentiment and message volume as of October 30 | Source: Stocktwits</figcaption></figure>One user said the market reaction reflected disappointment that the company’s longtime executive, now CEO, had signaled that Wall Street’s expectations for 2026 growth were too high, while also acknowledging a slowdown in new patient starts.<stembedurl>https://stocktwits.com/freddycan/message/634416837</stembedurl>Another user said they hoped analysts would issue more bullish reports and raise price targets, describing the selloff as “uncalled for.”<stembedurl>https://stocktwits.com/longshortequities/message/634409824</stembedurl>A third user took the opposite stance, calling the pullback a buying opportunity.<stembedurl>https://stocktwits.com/Okadarlan/message/634408938</stembedurl><a href="https://stocktwits.com/symbol/DXCM">Dexcom’s stock</a> has declined 12% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the DexCom logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Dexcom Stock Plunges 13% After-Hours As Q3 Margin Pressures Eclipse Record Profit — Retail Sees ‘Buy The Dip’ Setup

Investors focused on Dexcom’s lower gross margin of 61.3%, down about 170 basis points year-over-year, despite record revenue and earnings.

Equity

DexCom (DXCM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for DexCom (DXCM) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

DexCom (DXCM) Surpasses Q3 Earnings and Revenue Estimates

DexCom (DXCM) delivered earnings and revenue surprises of +7.02% and +2.72%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights: Revenue grew 22% year-over-year to $1.209...

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. (DexCom or the Company) (NASDAQ: DXCM) for violations of 10(b) and...

Insights Into DexCom (DXCM) Q3: Wall Street Projections for Key Metrics

Beyond analysts' top-and-bottom-line estimates for DexCom (DXCM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, Oct. 28, 2025 NEW...

DCXM ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. Investors

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired DexCom, Inc. (DexCom or the Company) (NASDAQ:DXCM) securities during the...

$DXCM Q3 &#39;25 Earnings Results &amp; Recap

Dexcom reported Q3 2025 revenue of $1.21B versus estimates of $1.18B and EPS of $0.61 versus estimates of $0.57, while raising revenue guidance to $4.63B-$4.65B, but lowering gross margin guidance to approximately 61%.

Stocktwits

 Q3 '25 Earnings Results & Recap

Dexcom reported Q3 2025 revenue of $1.21B versus estimates of $1.18B and EPS of $0.61 versus estimates of $0.57, while raising revenue guidance to $4.63B-$4.65B, but lowering gross margin guidance to approximately 61%.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.66	--	--	N/A
Q3 '25	$0.57	$0.61	7.18%	BEAT
Q2 '25	$0.44	$0.48	8.21%	BEAT
Q1 '25	$0.33	$0.32	-2.21%	MISSED
Q4 '24	$0.50	$0.45	-9.90%	MISSED

DXCM
Dexcom Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest DXCM News

DXCMDexcom Inc